Pirimicarb

Pirimicarb

SCHEMBL6738287

Cc1nc(N(C)C)nc(OC(=O)N(C)C)c1C.Cc1nc(N(C)C)nc(OC(=O)N(C)C)c1C

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.46
RAB9A P51151 1/20 0.37
HPGD P15428 1/20 0.37
NCEH1 Q6PIU2 3/20 0.36
TSPO P30536 2/20 0.36
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.33
POLB P06746 1/20 0.33
CYP1A2 P05177 1/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
CREBBP Q92793 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ALDH1A1 P00352 3/20 0.33
FAAH O00519 1/20 0.33
KMT2A Q03164 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pirimicarb SCHEMBL29407096 1.00 NPSR1 (0.46) NPSR1RAB9AHPGDNCEH1TSPO
Pirimicarb SCHEMBL26523 1.00 NPSR1 (0.46) NPSR1RAB9AHPGDNCEH1TSPO
Pirimicarb SCHEMBL7531666 0.95 NPSR1 (0.43) NPSR1RAB9AHPGDNCEH1TSPO
Pirimicarb SCHEMBL1423368 0.94 NPSR1 (0.43) NPSR1RAB9AHPGDNCEH1TSPO
SCHEMBL9595225 0.84 MEN1 (0.41) NPSR1RAB9AHPGDTSPOLMNA
SCHEMBL17602856 0.84 NPSR1 (0.43) NPSR1RAB9ANCEH1TSPOKDM4E
SCHEMBL1405587 0.84 NPSR1 (0.45) NPSR1RAB9ANCEH1TSPOKDM4E
SCHEMBL27336033 0.78 NPSR1 (0.45) NPSR1RAB9ANCEH1TSPOKDM4E
Butane SCHEMBL9595222 0.78 ALDH1A1 (0.36) NPSR1HPGDKDM4ELMNAHSD17B10
Pirimicarb SCHEMBL9121484 0.77 NPSR1 (0.35) NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6680065-B2 FOR TREATMENT OF WOODY PLANTS; EMPLOYED IN HOLLOW PREFORMED IN THE WOODY PLANT BAYER AKTIENGESELLSCHAFT (DE) 2004-01-20 US disclosed
US-6528079-B2 For treatment of woody plants; employed in a hollow preformed in the woody plant BAYER AKTIENGESELLSCHAFT (DE) 2003-03-04 US disclosed
US-20020061323-A1 SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2002-05-23 US disclosed
US-20010039248-A1 Shaped bodies which release agrochemical active substances PODSZUN WOLFGANG (DE) 2001-11-08 US disclosed
EP-0564945-B1 A method of controlling harmful insects BAYER AGROCHEM KK (JP) 2001-01-24 EP disclosed
US-6063393-A RODS OR PINS TO BE PRESSED INTO PLANTS NIHON BAYER AGROCHEM K.K. (JP) 2000-05-16 US disclosed
US-5837651-A SURFACTANTS, UREA, PESTICIDE OR PLANT GROWTH REGULATOR AS ACTIVE INGREDIENT; DELIVERING TO AGRICULTURAL OR HORTICULTURAL LOCUS AMERICAN CYANAMID COMPANY (US) 1998-11-17 US disclosed
US-5709871-A WATER DISPERSIBLE; MIXTURE OF SURFACTANTS AND UREA SHELL RESEARCH LIMITED (GB) 1998-01-20 US disclosed
EP-0564945-A1 A method of controlling harmful insects NIHON BAYER AGROCHEM K.K. (JP) 1993-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061323-A1 SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES AGL, CHMP4B, GUSB NPSR1 1348/4885RAB9A 1970/4885HPGD 1027/4885
US-20010039248-A1 Shaped bodies which release agrochemical active substances AGL, CHMP4B, GUSB NPSR1 1302/4885RAB9A 2025/4885HPGD 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.